<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01977924</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A00763-42</org_study_id>
    <nct_id>NCT01977924</nct_id>
  </id_info>
  <brief_title>Impact of Polyphenols on Endothelial Function in Obstructive Sleep Apnea</brief_title>
  <acronym>PolySAS</acronym>
  <official_title>Impact of Polyphenols on Endothelial Function in Obstructive Sleep Apnea: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity
      and mortality. Endothelial dysfunction, an early marker of vascular disease has been
      demonstrated in OSA. Regular treatment of OSA by continuous positive airway pressure (CPAP)
      improves endothelial function and is associated with a reduction in cardiovascular risk.
      Approximately 40% of patients with OSA are intolerant or insufficiently adherent to CPAP.
      Alternative treatments or adjuvants to the CPAP are needed.

      The polyphenols have demonstrated their effectiveness in improving endothelial function in
      patients with CV disease. No randomized controlled studies have evaluated the impact of PPR
      on the endothelial dysfunction associated with OSAHS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The endpoint is the change to one month of polyphenols treatment of the endothelial function
      measured by the index of hyperemic reactivity.

      The secondary endpoints are changes at one month of supplementation with polyphenols of
      ambulatory blood pressure measurement in 24 hours (MAPA), micro-circulatory responsiveness,
      the speed of the pulse wave and biological measurements (lipid profile, blood glucose,
      fasting insulin, leptin, adiponectin, hs-CRP, 8-isoprostane levels and cellular origin of
      microparticles).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>endothelial function measured by the index of hyperemic reactivity</measure>
    <time_frame>one month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>polyphenols</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>600 mg polyphenols (grape extract)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>microcrystalline cellulose</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>one month polyphenols supplementation (600mg)</intervention_name>
    <arm_group_label>polyphenols</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo (microcrystalline cellulose)</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:â€¢

          -  apnea hypopnea index &gt; 30

          -  accepting polyphenols supplementation

          -  Signed informed consent

        Exclusion Criteria:

          -  Epworth sleepiness scale &gt; 16/24

          -  Severe cardiac and/or respiratory disease

          -  BMI&gt;35 kg/m2

          -  Anemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>wojciech trzepizur, MD</last_name>
    <phone>+33(0) 214353695</phone>
    <email>wotrzepizur@chu-angers.fr</email>
  </overall_contact>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2013</study_first_submitted>
  <study_first_submitted_qc>November 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2013</study_first_posted>
  <last_update_submitted>November 12, 2013</last_update_submitted>
  <last_update_submitted_qc>November 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sleep apnea</keyword>
  <keyword>polyphenols</keyword>
  <keyword>endothelial function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

